Hanafusa T - Search Results

1

"Benifuuki" Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial.

Miyawaki M, Sano H, Imbe H, Fujisawa R, Tanimoto K, Terasaki J, Maeda-Yamamoto M, Tachibana H, Hanafusa T, Imagawa A. Miyawaki M, et al. Among authors: hanafusa t. Nutrients. 2018 Jul 19;10(7):924. doi: 10.3390/nu10070924. Nutrients. 2018. PMID: 30029523 Free PMC article. Clinical Trial.

2

Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners.

Hanafusa T, Imagawa A. Hanafusa T, et al. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):36-45; quiz 2p following 69. doi: 10.1038/ncpendmet0351. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17179928 Review.

3

Pathogenesis of fulminant type 1 diabetes.

Imagawa A, Hanafusa T. Imagawa A, et al. Among authors: hanafusa t. Rev Diabet Stud. 2006 Winter;3(4):169-77. doi: 10.1900/RDS.2006.3.169. Epub 2007 Feb 10. Rev Diabet Stud. 2006. PMID: 17487341 Free PMC article.

4

A renoprotective effect of low dose losartan in patients with type 2 diabetes.

Sawaki H, Terasaki J, Fujita A, Nakagawa S, Kanatsuna N, Sadahiro K, Isotani H, Imagawa A, Hanafusa T. Sawaki H, et al. Among authors: hanafusa t. Diabetes Res Clin Pract. 2008 Jan;79(1):86-90. doi: 10.1016/j.diabres.2007.08.004. Epub 2007 Sep 24. Diabetes Res Clin Pract. 2008. PMID: 17889959 Clinical Trial.

5

A case of fulminant type 1 diabetes mellitus after influenza B infection.

Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. Sano H, et al. Among authors: hanafusa t. Diabetes Res Clin Pract. 2008 Mar;79(3):e8-9. doi: 10.1016/j.diabres.2007.10.030. Epub 2008 Jan 4. Diabetes Res Clin Pract. 2008. PMID: 18177974

6

Insulitis in human type 1 diabetes.

Hanafusa T, Imagawa A. Hanafusa T, et al. Ann N Y Acad Sci. 2008 Dec;1150:297-9. doi: 10.1196/annals.1447.052. Ann N Y Acad Sci. 2008. PMID: 19120316

7

Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus.

Sano H, Terasaki J, Mishiba Y, Imagawa A, Hanafusa T. Sano H, et al. Among authors: hanafusa t. Biochem Biophys Res Commun. 2011 Jan 21;404(3):756-61. doi: 10.1016/j.bbrc.2010.12.020. Epub 2010 Dec 7. Biochem Biophys Res Commun. 2011. PMID: 21144822

8

Low CTLA-4 expression in CD4+ helper T-cells in patients with fulminant type 1 diabetes.

Haseda F, Imagawa A, Murase-Mishiba Y, Sano H, Hirano-Kuwata S, Ueda H, Terasaki J, Hanafusa T. Haseda F, et al. Among authors: hanafusa t. Immunol Lett. 2011 Sep 30;139(1-2):80-6. doi: 10.1016/j.imlet.2011.05.003. Epub 2011 May 17. Immunol Lett. 2011. PMID: 21620894

9

The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Miyasato M, Murase-Mishiba Y, Bessho M, Miyawaki M, Imbe H, Tsutsumi C, Tanimoto K, Imagawa A, Terasaki J, Hanafusa T. Miyasato M, et al. Among authors: hanafusa t. Clin Chim Acta. 2014 Jun 10;433:184-9. doi: 10.1016/j.cca.2014.03.018. Epub 2014 Mar 22. Clin Chim Acta. 2014. PMID: 24667697

10

Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps.

Imbe A, Tanimoto K, Inaba Y, Sakai S, Shishikura K, Imbe H, Tanimoto Y, Terasaki J, Imagawa A, Hanafusa T. Imbe A, et al. Among authors: hanafusa t. Endocr J. 2018 May 28;65(5):521-526. doi: 10.1507/endocrj.EJ17-0431. Epub 2018 Mar 6. Endocr J. 2018. PMID: 29515058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

695 results

Search Page